In the quest for more targeted lung cancer treatments, a researcher at the University of Missouri thinks the solution may...
Harnessing
As immunotherapy makes breakthrough progress in the treatment of small cell lung cancer (SCLC), predicting treatment outcomes has become a...
Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target...
